Biosidus erweitert seine Produktionskapazitäten für Biologika und stärkt seine weltweiten Lieferkapazitäten für Agalsidase beta

Agalsidase betaPositive

AI Analysis

Summary

Biosidus announced the commissioning of a new bioreactor facility to expand its biologics production capacity and strengthen global supply capabilities for Agalsidase beta.

Importance:3/10

Sentiment:

0.60

manufacturingcapacity expansionbiosimilaragalsidase betabiotech

Read the original article

Published by PR Newswire Biotech on August 27, 2026 2:26 AM

Read Original